← Back to Search

Emotion Regulation Training via Telehealth for Emotional Distress (ERT-P Trial)

N/A
Waitlist Available
Led By Douglas S Mennin, Ph.D.
Research Sponsored by Teachers College, Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18-65 years during the time of participation
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-treatment, post-treatment (4-5 weeks after starting treatment), 3-month follow-up, 9-month follow-up, 2-year follow-up
Awards & highlights

ERT-P Trial Summary

This trial will help people with mental health issues during the COVID-19 pandemic by delivering treatment via telehealth.

Who is the study for?
This trial is for New York residents aged 18-65 who are experiencing increased anxiety, stress, or depression due to the COVID-19 pandemic. Participants must have access to a mobile device with internet. It's not for those with active suicidal intent, substance dependence disorder in the past year, current psychosocial treatment, psychotic disorders, bipolar-I disorder, dementia or certain personality disorders.Check my eligibility
What is being tested?
The study tests Emotion Regulation Training delivered via telehealth aimed at helping individuals manage mental health issues like anxiety and depression during the COVID-19 pandemic. This open trial will provide evidence-based treatment remotely.See study design
What are the potential side effects?
Since this intervention involves psychological training rather than medication or medical procedures, traditional physical side effects are not expected; however participants may experience emotional discomfort as they confront and work through their distress.

ERT-P Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

ERT-P Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-treatment (4-5 weeks after starting treatment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-treatment (4-5 weeks after starting treatment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in Anxiety, Depression, and Distress: Depression Anxiety Stress Scale (DASS)
Changes in Anxiety, Depression, and Distress: Mood and Anxiety Symptoms Questionnaire (MASQ)
Changes in Functional Impairment: Sheehan Disability Scale (SDS)
+4 more
Secondary outcome measures
Satisfaction and Usability of Treatment: Client Satisfaction Questionnaire (CSQ)
Semi-Weekly Measures of Treatment Changes in Anxiety: Patient-Reported Outcomes Measurement Information System (PROMIS): Anxiety
Semi-Weekly Measures of Treatment Changes in Attentional Regulation: The Attentional Control Scale (ACS)
+7 more

ERT-P Trial Design

1Treatment groups
Experimental Treatment
Group I: Emotion Regulation Training via TelehealthExperimental Treatment1 Intervention
All participants will receive 9 sessions of Emotion Regulation Training delivered via telehealth. These individualized therapy sessions are 1-hour in length and occur semi-weekly over the course of four weeks.

Who is running the clinical trial?

University of MichiganOTHER
1,797 Previous Clinical Trials
6,377,958 Total Patients Enrolled
1 Trials studying Emotional Distress
107 Patients Enrolled for Emotional Distress
Teachers College, Columbia UniversityLead Sponsor
24 Previous Clinical Trials
5,757 Total Patients Enrolled
2 Trials studying Emotional Distress
204 Patients Enrolled for Emotional Distress
Douglas S Mennin, Ph.D.Principal InvestigatorTeachers College, Columbia University

Media Library

Emotion Regulation Training via Telehealth Clinical Trial Eligibility Overview. Trial Name: NCT04615416 — N/A
Emotional Distress Research Study Groups: Emotion Regulation Training via Telehealth
Emotional Distress Clinical Trial 2023: Emotion Regulation Training via Telehealth Highlights & Side Effects. Trial Name: NCT04615416 — N/A
Emotion Regulation Training via Telehealth 2023 Treatment Timeline for Medical Study. Trial Name: NCT04615416 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aim of this medical research?

"The primary outcome of this medical trial, measured at Pre-Treatment, Post-Treatment (4 to 5 weeks after initiating treatment), 3 Month Follow-Up, 9 Month Follow Up and 2 Year Follow Up is changes in rumination. Other secondary outcomes include Client Satisfaction Questionnaire (CSQ) for gauging satisfaction with the intervention as well as Brief Rumination Reflection Questionnaire (RRQ) and Patient Reported Outcomes Measurement Information System (PROMIS): Anxiety scores looking at changes in anxiety levels."

Answered by AI

Are individuals aged 40 and above being considered for this experiment?

"Adhering to the entry requirements for this trial, potential participants must be aged 18 or older yet below 65."

Answered by AI

Is enrollment for this trial actively taking place?

"Based on the information hosted on clinicaltrials.gov, this medical study is not presently looking for participants at this time. First posted in May of 2020, it was last updated in June 2022 and has since concluded its recruitment phase; nonetheless, there are 2370 other trials actively recruiting candidates currently."

Answered by AI

For whom is this experimental study most suitable?

"This research requires 100 participants aged 18-65 who have been afflicted with depression due to the COVID-19 pandemic, and that they possess a device connected to the internet (e.g., smartphone, tablet)."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
Teachers College, Columbia University
What portion of applicants met pre-screening criteria?
Met criteria
~20 spots leftby Apr 2025